Search
for
Sort by
Research 721–750 of 1000+
- Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Low Starch/Low Dairy Diet Results in Successful Treatment of Obesity and Co- Morbidities Linked to Polycystic Ovary Syndrome (PCOS)
- Endocrine disorders and hormonal therapy for adolescent acne
- Polycystic Ovary Syndrome
- Hidradenitis Suppurativa
- Acne in Dark Skin
- Factors associated with early-onset androgenetic alopecia: A scoping review
- POLYCYSTIC OVARY SYNDROME (PCOS): DIAGNOSIS, PATHOPHYSIOLOGY AND CONTEMPORARY THERAPEUTIC APPROACHES
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Epicardial Fat Thickness in Children with Classic Congenital Adrenal Hyperplasia
- Serum irisin level in patients with acne vulgaris
- Epicardial fat thickness in children with classic congenital adrenal hyperplasia
- Dermatology of androgen-related disorders
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Exercise activates the PI3K-AKT signal pathway by decreasing the expression of 5α-reductase type 1 in PCOS rats
- Increased Insulin Sensitivity by Metformin Enhances Intense-Pulsed-Light-Assisted Hair Removal in Patients with Polycystic Ovary Syndrome
- Exploring the therapeutic potential of phytochemicals apigenin and ellagic acid in managing polycystic ovarian syndrome and its comorbidities: a comprehensive review
- Effect of Exercise Interventions on Metabolic, Reproductive and Mental Health in Overweight Women with Polycystic Ovary Syndrome
- GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity
- Defective Expression of the Gap Junction Protein Pannexin-1 Channel Contributes to the Formation of PCOS-Realted Androgenetic Alopecia
- Association of Gly972Arg variant of insulin receptor subtrate-1 and Gly1057Asp variant of insulin receptor subtrate-2 with polycystic ovary syndrome in the Chinese population
- Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Normal Pubertal Development in Daughters of Women With PCOS: A Controlled Study
- Dermatologic manifestations of endocrine disorders
- Evaluation Asprosin Level in Polycystic Ovary Syndrome and Its Association with Fetuin a and Some Biochemical Parameter
- Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making
- The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date
- Polycystic ovary syndrome: A review for dermatologists